Small-fibre neuropathies--advances in diagnosis, pathophysiology and management. - Wikidata - awgldk - TriplyDB

Small-fibre neuropathies--advances in diagnosis, pathophysiology and management.

Small-fibre neuropathies--advances in diagnosis, pathophysiology and management.

http://www.wikidata.org/entity/Q34277762

about

The search for novel analgesics: targets and mechanisms Neuropathic Pain due to Small Fiber Neuropathy in Aging: Current Management and Future Prospects The clinical approach to small fibre neuropathy and painful channelopathy Chemotherapy-induced neuropathies-a growing problem for patients and health care providers Enhanced excitability of primary sensory neurons and altered gene expression of neuronal ion channels in dorsal root ganglion in paclitaxel-induced peripheral neuropathy Gain-of-function Nav1.8 mutations in painful neuropathy.Mitochondrial fission augments capsaicin-induced axonal degeneration ARA 290, a nonerythropoietic peptide engineered from erythropoietin, improves metabolic control and neuropathic symptoms in patients with type 2 diabetes.Small nerve fiber quantification in the diagnosis of diabetic sensorimotor polyneuropathy: comparing corneal confocal microscopy with intraepidermal nerve fiber density No Fabry Disease in Patients Presenting with Isolated Small Fiber Neuropathy Adult-onset painful axonal polyneuropathy caused by a dominant NAGLU mutation.Ca2+ toxicity due to reverse Na+/Ca2+ exchange contributes to degeneration of neurites of DRG neurons induced by a neuropathy-associated Nav1.7 mutation Human pain and genetics: some basics Quality of life in polyneuropathy: association with biomarkers of small fiber impairment.Amplitudes of Pain-Related Evoked Potentials Are Useful to Detect Small Fiber Involvement in Painful Mixed Fiber Neuropathies in Addition to Quantitative Sensory Testing - An Electrophysiological Study.Efficacy, safety, and tolerability of lacosamide in patients with gain-of-function Nav1.7 mutation-related small fiber neuropathy: study protocol of a randomized controlled trial-the LENSS study.Intravenous immunoglobulin therapy for small fiber neuropathy: study protocol for a randomized controlled trial Electrochemical Skin Conductance Correlates with Skin Nerve Fiber Density.Effective gene expression in the rat dorsal root ganglia with a non-viral vector delivered via spinal nerve injection.A painful neuropathy-associated Nav1.7 mutant leads to time-dependent degeneration of small-diameter axons associated with intracellular Ca2+ dysregulation and decrease in ATP levels.Genetic aspects of sodium channelopathy in small fiber neuropathy.Prurigo nodularis: an update on etiopathogenesis and therapy.New and developing drugs for the treatment of neuropathic pain in diabetes.Fabry disease: a rare cause of neuropathic pain.Reappraising neuropathic pain in humans--how symptoms help disclose mechanisms.The role of sodium channels in painful diabetic and idiopathic neuropathy.Painful neuropathies: the emerging role of sodium channelopathies.Structural and functional assessment of skin nerve fibres in small-fibre pathology.Corneal confocal microscopy in chronic inflammatory demyelinating polyneuropathy.The reduction of intraepidermal P2X3 nerve fiber density correlates with behavioral hyperalgesia in a rat model of nerve injury-induced pain.Small fiber neuropathy: Getting bigger!New technologies for the assessment of neuropathies.Testing nerves: an overview of investigations for neuropathy.Improving assessment in small fiber neuropathy.Gain-of-function mutation of a voltage-gated sodium channel NaV1.7 associated with peripheral pain and impaired limb development.Acute painful autoimmune neuropathy: A variant of Guillain-Barré syndrome.Tracking Epidermal Nerve Fiber Changes in Asian Macaques: Tools and Techniques for Quantitative Assessment.The Domain II S4-S5 Linker in Nav1.9: A Missense Mutation Enhances Activation, Impairs Fast Inactivation, and Produces Human Painful Neuropathy.Low threshold unmyelinated mechanoafferents can modulate pain.Measurement of small fibre pain threshold values for the early detection of diabetic polyneuropathy.

P2860

Q24288817-C65B4920-ADB8-4862-97AF-F758F34805E4 Q26799409-D57B04E5-4472-4ADB-AFA9-1632DFA467F5 Q26863734-35BBA802-B8AA-446C-B775-8BC706432957 Q28818565-2287EB59-D9F6-4726-85D0-20FABD2CBAB6 Q33650951-C917A94F-5F19-4D6A-8597-F1326DA44689 Q34309236-19686C55-80B5-4783-814D-BDFCB930E8E5 Q34807873-B6470AAB-2C1C-464D-A9CB-4B498B586B43 Q35192848-EED04276-05B7-467F-A268-28EBF22243F5 Q35630724-6A793D8F-20AC-48F4-8315-EEA330E04AC8 Q35920645-8CE24DAA-FBF0-4153-80AC-E3892A2D9AB8 Q35974498-5326B801-7FB5-4A14-A9EB-DDC8F75B8668 Q36032974-F80CDBFE-3A58-4F4E-8918-C45851294654 Q36110585-52DEE64E-41A1-46E8-913E-07F65CFD4CD0 Q36165248-8E9B443D-8FD5-4E2D-A7EE-D6CB6E184255 Q36349888-AC87126E-DD56-4E45-98A8-7CEA69E1642D Q37057835-1B11822B-528B-467D-B555-9BBA4232406F Q37113332-8F2A87FB-7954-4487-878D-FDB9C4FD9FBE Q37198217-96125403-D9C4-4C33-A57D-28F9FF9F0265 Q37343097-E6AC9528-8C3D-4A84-AA65-D2F07609E900 Q37403813-5A71103C-7429-4BFA-9370-2A883B8FA819 Q38026870-A38035BF-6664-4232-8E62-C535B0C7B515 Q38114469-0108C378-53F0-4242-AF9C-4DF28723F846 Q38114817-5006C34D-30AD-4AEB-9EA3-D5FA1AFF4596 Q38133441-D1233FF4-B3CF-4658-A773-58BA4031034D Q38135692-62817847-DBD9-4F9D-908A-FCFAAF808797 Q38241746-28B29E06-138B-4544-941B-9C33A4520E28 Q38253772-D915349A-A26D-49A6-8093-310AD91EB652 Q38302767-5D5A09D6-9E3D-4D55-A742-001EF4C90EC7 Q38334722-B83D7307-83F0-4A94-88C9-A5D5BC01101F Q38620924-F88C5079-619E-4034-A091-FE6DF50D38C8 Q38731621-22300FEB-5283-4251-8987-EDB53A66E726 Q38743705-B4A9FA09-43F5-4DED-B2CB-CBEA175CC7D0 Q38957855-ADCF2B98-DC27-4185-80BF-5205686FFD8C Q38991218-E39C02DB-2CED-46EC-9551-D8AE052C35A0 Q39157361-C61CBBD7-106A-4E75-9622-28CAC4B7BB52 Q40151162-DD61CB01-6FA1-4916-8E61-B923420DB303 Q40655635-03B7A9B0-B6DF-48FA-9E53-F9E3FC6CEFC9 Q41190621-C0017508-892F-47A4-9B73-F77F8BEF130A Q41712041-67017AA6-FDBF-40F2-AE07-8BD23548810B Q41741182-F9DC1CC7-088B-4FD2-BBBE-1A688E127760

P2860

Small-fibre neuropathies--advances in diagnosis, pathophysiology and management.

http://www.wikidata.org/entity/Q34277762

description

2012 nî lūn-bûn

@nan

2012 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Small-fibre neuropathies--advances in diagnosis, pathophysiology and management.

@ast

Small-fibre neuropathies--advances in diagnosis, pathophysiology and management.

@en

Small-fibre neuropathies--advances in diagnosis, pathophysiology and management.

@nl

type

label

Small-fibre neuropathies--advances in diagnosis, pathophysiology and management.

@ast

Small-fibre neuropathies--advances in diagnosis, pathophysiology and management.

@en

Small-fibre neuropathies--advances in diagnosis, pathophysiology and management.

@nl

prefLabel

Small-fibre neuropathies--advances in diagnosis, pathophysiology and management.

@ast

Small-fibre neuropathies--advances in diagnosis, pathophysiology and management.

@en

Small-fibre neuropathies--advances in diagnosis, pathophysiology and management.

@nl

P1433

Q34277762-8E60BECF-60FC-4922-A724-00E8D95E4294

P1476

Q34277762-55461209-278B-4DC6-A617-AFADEF9141CD

P2093

Q34277762-357349F8-A11C-412F-90BA-C46C4C847DBE

Q34277762-524D259D-8D68-4CD0-BE28-E0CD5DC565F2

Q34277762-85A442AB-8A88-48BC-AAE6-FC100356C21D

Q34277762-9B01C6B2-2583-4EFB-BB86-C2B4182F9697

Q34277762-EC8C35C4-C154-47C2-903A-0CDE9E15C92E

P2860

Q34277762-00764F15-15D5-4C89-8F1E-82F3477056C9

Q34277762-02E9F354-5280-402B-92EC-8DE4BC966B88

Q34277762-02F7A9C3-F6EA-4AE6-ADBB-87C46684A9E1

Q34277762-03332DF9-581C-4E1C-B525-5C67E04BA7C8

Q34277762-050C0E56-C0D8-4B78-8C81-672756FF9E47

Q34277762-06294E4F-076C-4DEB-817F-4C70E23C3EF8

Q34277762-07560E02-93FB-4A09-9BE2-14C117475283

Q34277762-07C415FF-680F-4E9C-89CB-55328D64756B

Q34277762-0D52F75D-A896-4AF7-8102-9D2D63B4F28C

Q34277762-0EB57D82-56E2-4451-96A7-26B7684CC29C

P2888

Q34277762-331F5812-0D0A-4481-86D4-D315F8D621E7

P304

Q34277762-3AE4572F-8E41-47CF-BFCD-47FEC08133F9

P31

Q34277762-7D672525-DE61-4A94-BF36-E15208EC2B41

P356

Q34277762-4FCE26E5-6012-4C9A-8116-265EB2851670

P407

Q34277762-FEE440D9-82B5-4CE1-BD33-A0EC569E8492

P433

Q34277762-A6ECC034-4EDE-493B-95FF-96E71308BFA9

P478

Q34277762-F44EBD89-A70D-4B55-8A34-E52971F21A1A

P577

Q34277762-2FE7B59C-C388-45B0-82D6-F67738042EFC

P5875

Q34277762-0C29E2E9-26CD-4B0B-8D13-250DAEB9C241

P6179

Q34277762-046692FA-838C-4D7D-A8CE-E7CA92E91EE7

P698

Q34277762-CA4454BE-4AD5-447F-BE80-20EA66481482

P921

Q34277762-32210819-1A2D-47A9-BC64-26E95A683D55

P356

NRNEUROL.2012.97

P1433

Nature Reviews Neurology

P1476

Small-fibre neuropathies--advances in diagnosis, pathophysiology and management.

@en

P2093

Catharina G Faber

http://www.w3.org/2001/XMLSchema#string

Giuseppe Lauria

http://www.w3.org/2001/XMLSchema#string

Ingemar S Merkies

http://www.w3.org/2001/XMLSchema#string

Janneke G Hoeijmakers

http://www.w3.org/2001/XMLSchema#string

Stephen G Waxman

http://www.w3.org/2001/XMLSchema#string

P2860

Early diagnosis of peripheral nervous system involvement in Fabry disease and treatment of neuropathic pain: the report of an expert panel

Small-fiber neuropathy

Histopathologic findings in primary erythromelalgia are nonspecific: special studies show a decrease in small nerve fiber density

European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripher

Intraepidermal nerve fiber density at the distal leg: a worldwide normative reference study

Inhibiting TRPA1 ion channel reduces loss of cutaneous nerve fiber function in diabetic animals: sustained activation of the TRPA1 channel contributes to the pathogenesis of peripheral diabetic neuropathy

Gain of function NaV1.7 mutations in idiopathic small fiber neuropathy

Morphology of corneal nerves using confocal microscopy.

C- and A delta-fiber components of heat-evoked cerebral potentials in healthy human subjects.

Dysfunction of small myelinated afferents in diabetic polyneuropathy, as assessed by laser evoked potentials.

P2888

nrneurol.2012.97

P304

369-379

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRNEUROL.2012.97

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2012-05-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225068897

http://www.w3.org/2001/XMLSchema#string

P6179

1001450413

http://www.w3.org/2001/XMLSchema#string

P698

22641108

http://www.w3.org/2001/XMLSchema#string

P921

pathophysiology